Overview

Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study is designed to explore the efficacy and safety of DA-4001 after topical application in male patients with androgenetic alopecia Design : Randomized, double-blind, active-controlled study Investigational Product : Finasteride, minoxidil
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Dong-A ST Co., Ltd.
Treatments:
Minoxidil